1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6B4F8267EB01C648985257E51006AEF46
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-medical-device-quality-2014-15-inspection-production-activities?opendocument
18
19opendocument
2018.97.14.87
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Quality, Compliance and Regulatory » Assuring Quality Programs

Benchmarking Medical Device Quality 2014-15: Inspection and Production Activities

ID: 5364


Features:

5 Info Graphics

27 Data Graphics

600+ Metrics


Pages/Slides: 43


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Benchmarking Medical Device Quality 2014-15: Inspection and Production"

STUDY OVERVIEW

Medical device companies must produce quality products and meet compliance standards. Understanding how to balance these goals is challenging, especially with the ever-changing regulatory landscape. Undoubtedly, the quality function plays a significant role in ensuring that its organization meets these goals efficiently and effectively.

Best Practices, LLC undertook this study to help quality leaders better understand inspection and compliance activities within the quality function. The study includes metrics around the level of ownership the quality function has for key inspection/production activities, the extent of inspection/production quality activities performed in low-wage markets, and supplier and software issues related to inspection and production activities. Research findings provide evidence-based benchmarks around these issues so quality leaders can compare their efforts with industry peers.

This study contains a Large Company Segment (LCS) that is made up of 11 companies.


KEY TOPICS

  • Inspection/Production Activities
  • Working with Suppliers
  • Software Management Issue



KEY METRICS
  • Scope of Responsibility of the Quality Organization in Inspection/Production
  • Process for Isolating Critical to Quality Parameters
  • Inspection/Production Quality Assurance Activities Conducted at Company Sites in Low-Wage Markets
  • Inspection/Production Quality Assurance Activities Conducted by Third-Party Vendors in Low-Wage Markets
  • Location of Toxicology/Biocompatibility Internal Inspections
  • Number of Active Clinical Trials
  • Active Clinical Trials to Internal Clinical Trial Audits
  • Number of Audits at Investigational Clinical Sites
  • Direct Material Suppliers Per $100 Millions In Revenue
  • Percent Incoming Batches Requiring Detailed Inspections
  • Off-Floor Lab Testing of Production Batches
  • Metrics Used to Assess Supply Chain Risk
  • Effectiveness of Production Risk Metrics
  • Document Types Reviewed by Software Quality Assurance
  • Groups Owning Software Validation Activity
SAMPLE KEY FINDINGS
  • Compliance Leads Top Challenges: The benchmark class identified regulatory issues or compliance (24%) operations/processes/structures (24%), and talent management issues (16%) as the top three types of industry challenges facing them in the coming 12 to 24 months.

METHODOLOGY
  • Best Practices, LLC designed and deployed a custom benchmarking survey to executives at 21 leading Medical Device companies.  This study has two segments: Total Benchmark Class (TBC) made up of 21 companies and a Large Company Segment (LCS) that is made up of 11 companies.
Industries Profiled:
Medical Device; Pharmaceutical; Health Care


Companies Profiled:
3M Pharmaceuticals; DePuy Synthes; Baxter Healthcare; Atri Cure; Beckman Coulter; BMC Medical; Becton Dickinson; Bio Tek; Boston Scientific; Cook Medical; Covidien; Endologix; Edwards Lifesciences; Helmer Scientific; Ethicon; GE Healthcare; Medtronic; BARD; Haemonetics Corporation; Invacare Corporation; Lake Region Medical

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.